Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
J Pept Sci. 2023 Jan;29(1):e3457. doi: 10.1002/psc.3457. Epub 2022 Nov 9.
Protein-protein interactions (PPI) are involved in all cellular processes and many represent attractive therapeutic targets. However, the frequently rather flat and large interaction areas render the identification of small molecular PPI inhibitors very challenging. As an alternative, peptide interaction motifs derived from a PPI interface can serve as starting points for the development of inhibitors. However, certain proteins remain challenging targets when applying inhibitors with a competitive mode of action. For that reason, peptide-based ligands with an irreversible binding mode have gained attention in recent years. This review summarizes examples of covalent inhibitors that employ peptidic binders and have been tested in a biological context.
蛋白质-蛋白质相互作用(PPI)参与所有细胞过程,其中许多是有吸引力的治疗靶点。然而,由于相互作用区域通常较为平坦且较大,因此识别小分子 PPI 抑制剂极具挑战性。作为替代方案,可以从 PPI 界面中衍生出肽相互作用基序,作为抑制剂开发的起点。然而,当应用具有竞争性作用模式的抑制剂时,某些蛋白质仍然是具有挑战性的靶标。出于这个原因,近年来具有不可逆结合模式的基于肽的配体受到了关注。本文综述了在生物环境中进行测试的、采用肽结合物的共价抑制剂的实例。